MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sales and
maturities of marketable...
$39,298K
Proceeds from issuance of
common stock, net of...
$13,267K
Proceeds from stock
options exercised
$273K
Net cash provided
(used) by investing...
$33,027K
Net cash provided by
financing activities
$13,540K
Canceled cashflow
$6,271K
Net change in cash
and cash...
$2,195K
Canceled cashflow
$44,372K
Purchases of marketable
securities
$5,917K
Purchases of property and
equipment
$354K
Stock-based compensation
expense
$5,183K
Non-cash operating lease
expense
$730K
Accrued expenses and
other current...
$311K
Depreciation and
amortization
$253K
Other non-current
assets
-$72K
Net cash provided
(used) in operating...
-$44,372K
Canceled cashflow
$6,549K
Net loss
-$49,076K
Prepaid expenses and
other current assets
$519K
Operating lease
liabilities
-$508K
Accounts payable
-$416K
Amortization of
premium/discount on marketable...
-$401K
Realized gain on
investments
$1K
Back
Back
Cash Flow
source: myfinsight.com
Vigil Neuroscience, Inc. (VIGL)
Vigil Neuroscience, Inc. (VIGL)